DK0750626T3 - Stannius corpuscle protein, stanniocalcin - Google Patents
Stannius corpuscle protein, stanniocalcinInfo
- Publication number
- DK0750626T3 DK0750626T3 DK94923154T DK94923154T DK0750626T3 DK 0750626 T3 DK0750626 T3 DK 0750626T3 DK 94923154 T DK94923154 T DK 94923154T DK 94923154 T DK94923154 T DK 94923154T DK 0750626 T3 DK0750626 T3 DK 0750626T3
- Authority
- DK
- Denmark
- Prior art keywords
- polypeptides
- stannius
- stanniocalcin
- polypeptide
- encoding
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108010052178 teleocalcin Proteins 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 abstract 6
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 6
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 6
- 108020004414 DNA Proteins 0.000 abstract 1
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 229910019142 PO4 Inorganic materials 0.000 abstract 1
- 101710183756 Stanniocalcin Proteins 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 238000003556 assay Methods 0.000 abstract 1
- 230000003185 calcium uptake Effects 0.000 abstract 1
- 230000029142 excretion Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000035772 mutation Effects 0.000 abstract 1
- 150000007523 nucleic acids Chemical group 0.000 abstract 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 abstract 1
- 239000010452 phosphate Substances 0.000 abstract 1
- 238000010188 recombinant method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/55—Fab or Fab'
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/834—Urine; urinary system
- Y10S530/835—Kidney
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Endocrinology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Obesity (AREA)
- Physical Education & Sports Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Biotechnology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Nutrition Science (AREA)
- Epidemiology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
The present invention relates to human Corpuscles of Stannius polypeptides and DNA (RNA) encoding such polypeptides. Also provided is a procedure for producing such polypeptides by recombinant techniques and antagonists against such polypeptides. Human Corpuscles of Stannius protein inhibits calcium uptake and reduces renal excretion of phosphate. Also provided is a diagnostic assay to detect mutations in the nucleic acid sequence encoding the polypeptide and for altered concentrations of the polypeptide in a sample derived from a host.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/208,005 US5837498A (en) | 1994-03-08 | 1994-03-08 | Corpuscles of stannius protein, stanniocalcin |
| PCT/US1994/005136 WO1995024411A1 (en) | 1994-03-08 | 1994-05-09 | Corpuscles of stannius protein, stanniocalcin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0750626T3 true DK0750626T3 (en) | 2000-11-20 |
Family
ID=22772838
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK94923154T DK0750626T3 (en) | 1994-03-08 | 1994-05-09 | Stannius corpuscle protein, stanniocalcin |
Country Status (15)
| Country | Link |
|---|---|
| US (5) | US5837498A (en) |
| EP (1) | EP0750626B1 (en) |
| JP (1) | JP3687974B2 (en) |
| KR (1) | KR100338583B1 (en) |
| CN (2) | CN1560080A (en) |
| AT (1) | ATE197155T1 (en) |
| AU (1) | AU684297B2 (en) |
| CA (1) | CA2184905A1 (en) |
| DE (1) | DE69426209T2 (en) |
| DK (1) | DK0750626T3 (en) |
| ES (1) | ES2151557T3 (en) |
| GR (1) | GR3035099T3 (en) |
| PT (1) | PT750626E (en) |
| WO (1) | WO1995024411A1 (en) |
| ZA (1) | ZA943702B (en) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5837498A (en) * | 1994-03-08 | 1998-11-17 | Human Genome Scienes, Inc. | Corpuscles of stannius protein, stanniocalcin |
| JPH10509036A (en) * | 1994-11-10 | 1998-09-08 | ヒューマン・ジェノム・サイエンシズ・インコーポレイテッド | Human stanniocalcin-α |
| US6008322A (en) * | 1996-04-02 | 1999-12-28 | Zymogenetics, Inc. | Stanniocalcin-2 |
| WO1999033864A1 (en) * | 1997-12-26 | 1999-07-08 | Daiichi Pharmaceutical Co., Ltd. | Peptide derivatives |
| WO2000016795A1 (en) * | 1998-09-17 | 2000-03-30 | Snow Brand Milk Products Co., Ltd. | Preventives and/or remedies for obesity |
| CA2387685A1 (en) * | 1999-10-27 | 2001-05-03 | Human Genome Sciences, Inc. | Stanniocalcin proteins and nucleic acids and methods based thereon |
| US6902890B1 (en) * | 1999-11-04 | 2005-06-07 | Diadexus, Inc. | Method of diagnosing monitoring, staging, imaging and treating cancer |
| US20040254102A1 (en) * | 2000-07-11 | 2004-12-16 | Yuji Yoshiko | Remedies for bone diseases |
| US20040009171A1 (en) * | 2001-10-18 | 2004-01-15 | Genentech, Inc. | Methods for the treatment of carcinoma |
| EP1442062A4 (en) * | 2001-10-18 | 2005-11-09 | Genentech Inc | Methods for the treatment of carcinoma |
| US7056685B1 (en) | 2002-11-05 | 2006-06-06 | Amgen Inc. | Receptor ligands and methods of modulating receptors |
| US8759298B2 (en) | 2010-05-03 | 2014-06-24 | Scott & White Healthcare | Protein therapy for corneal inflammation, epithelial wound healing, and photoreceptor degeneration |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5447841A (en) * | 1986-01-16 | 1995-09-05 | The Regents Of The Univ. Of California | Methods for chromosome-specific staining |
| WO1988003949A1 (en) * | 1986-11-21 | 1988-06-02 | Howard Florey Institute Of Experimental Physiology | The cs protein of the corpuscles of stannius |
| US5491224A (en) * | 1990-09-20 | 1996-02-13 | Bittner; Michael L. | Direct label transaminated DNA probe compositions for chromosome identification and methods for their manufacture |
| US5538869A (en) * | 1990-12-13 | 1996-07-23 | Board Of Regents, The University Of Texas System | In-situ hybridization probes for identification and banding of specific human chromosomes and regions |
| US5866344A (en) * | 1991-11-15 | 1999-02-02 | Board Of Regents, The University Of Texas System | Antibody selection methods using cell surface expressed libraries |
| US5545524A (en) * | 1991-12-04 | 1996-08-13 | The Regents Of The University Of Michigan | Compositions and methods for chromosome region-specific probes |
| US5837498A (en) * | 1994-03-08 | 1998-11-17 | Human Genome Scienes, Inc. | Corpuscles of stannius protein, stanniocalcin |
-
1994
- 1994-03-08 US US08/208,005 patent/US5837498A/en not_active Expired - Lifetime
- 1994-05-09 CN CNA2004100027180A patent/CN1560080A/en active Pending
- 1994-05-09 AT AT94923154T patent/ATE197155T1/en not_active IP Right Cessation
- 1994-05-09 CN CNB941950522A patent/CN1178950C/en not_active Expired - Fee Related
- 1994-05-09 PT PT94923154T patent/PT750626E/en unknown
- 1994-05-09 KR KR1019960704922A patent/KR100338583B1/en not_active IP Right Cessation
- 1994-05-09 DK DK94923154T patent/DK0750626T3/en active
- 1994-05-09 ES ES94923154T patent/ES2151557T3/en not_active Expired - Lifetime
- 1994-05-09 AU AU73109/94A patent/AU684297B2/en not_active Ceased
- 1994-05-09 JP JP52342195A patent/JP3687974B2/en not_active Expired - Fee Related
- 1994-05-09 WO PCT/US1994/005136 patent/WO1995024411A1/en active IP Right Grant
- 1994-05-09 EP EP94923154A patent/EP0750626B1/en not_active Expired - Lifetime
- 1994-05-09 CA CA002184905A patent/CA2184905A1/en not_active Abandoned
- 1994-05-09 DE DE69426209T patent/DE69426209T2/en not_active Expired - Fee Related
- 1994-05-26 ZA ZA943702A patent/ZA943702B/en unknown
-
1995
- 1995-04-28 US US08/431,117 patent/US5994301A/en not_active Expired - Fee Related
-
1998
- 1998-03-11 US US09/038,597 patent/US5877290A/en not_active Expired - Lifetime
-
2000
- 2000-12-18 GR GR20000402787T patent/GR3035099T3/en not_active IP Right Cessation
-
2002
- 2002-04-05 US US10/116,051 patent/US20020146791A1/en not_active Abandoned
-
2005
- 2005-03-10 US US11/076,158 patent/US7326537B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| WO1995024411A1 (en) | 1995-09-14 |
| CN1560080A (en) | 2005-01-05 |
| AU684297B2 (en) | 1997-12-11 |
| US5877290A (en) | 1999-03-02 |
| ZA943702B (en) | 1995-11-27 |
| CN1143371A (en) | 1997-02-19 |
| US5837498A (en) | 1998-11-17 |
| CN1178950C (en) | 2004-12-08 |
| GR3035099T3 (en) | 2001-03-30 |
| ES2151557T3 (en) | 2001-01-01 |
| US5994301A (en) | 1999-11-30 |
| US7326537B2 (en) | 2008-02-05 |
| EP0750626B1 (en) | 2000-10-25 |
| DE69426209D1 (en) | 2000-11-30 |
| US20050208552A1 (en) | 2005-09-22 |
| CA2184905A1 (en) | 1995-09-14 |
| ATE197155T1 (en) | 2000-11-15 |
| PT750626E (en) | 2001-03-30 |
| KR970701724A (en) | 1997-04-12 |
| JP3687974B2 (en) | 2005-08-24 |
| US20020146791A1 (en) | 2002-10-10 |
| EP0750626A1 (en) | 1997-01-02 |
| AU7310994A (en) | 1995-09-25 |
| KR100338583B1 (en) | 2002-11-14 |
| EP0750626A4 (en) | 1997-06-11 |
| DE69426209T2 (en) | 2001-06-07 |
| JPH09511140A (en) | 1997-11-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK165506C (en) | PROTEIN PREPARATION WITH COAGULATING ACTIVITY AND PROCEDURE FOR PREPARING THEREOF | |
| BR8606615A (en) | COMPLEMENTARY POLIPEPTIDEOS TO PEPTIDEOS OR PROTEINS HAVING A SEQUENCE OF AMINO ACIDS OR NUCLEOTIDE CODING SEQUENCE KNOWN AT LEAST PARTIALLY AND DESIGN METHODS OF THE SAME | |
| ATE117437T1 (en) | TEST OF BODY FLUID TO MEASURE BONE RESORPTION. | |
| ATE348843T1 (en) | DETECTION OF TSH RECEPTOR AUTOANTIBODIES USING AFFINITY PURIFIED ANTIBODIES | |
| DK0750626T3 (en) | Stannius corpuscle protein, stanniocalcin | |
| WO2002082075A3 (en) | Method for detecting chronic dementia diseases, and corresponding peptides and detection reagents | |
| ATE354638T1 (en) | HUMAN TISSUE INHIBITOR OF METALLOPROTEINASE-4 | |
| ATE328281T1 (en) | METHOD FOR DIAGNOSING ABNORMAL BONE METABOLIC | |
| EP0789076A3 (en) | G protein coupled receptor proteins, their production and use | |
| JPS646219A (en) | Peptide having promoting action on activation of protein c by thrombin | |
| DE69736158D1 (en) | Glutamine: fructose-6-phosphate amidotransferase (GFAT), its preparation and use | |
| EP0846763A3 (en) | A protein phosphatase 1 binding protein, R5 | |
| EP1134286A3 (en) | Adamts polypeptides, nucleic acids encoding them, and uses thereof | |
| Wakui et al. | High-yield purification of the complex-forming glycoprotein in urine from normal and abnormal subjects. | |
| DE MARCUCCI et al. | Immune-mapping as a specific and sensitive probe for the characterization of proteins |